Wednesday, November 1, 2017

Benefits of #Serrapeptase



 Amazon    eBay


In the U.S., Serrapeptase is classified as a dietary supplement. Serrapeptase is used for painful conditions including back pain, osteoarthritis, rheumatoid arthritis, osteoporosis, fibromyalgia, carpel tunnel syndrome, migraine headache, and tension headache.



What foods contain serrapeptase?
While there are no foods that actually contain serrapeptase, doctors who recommend this enzyme suggest that people to stick to a mainly Mediterranean diet. Eat organic meats, fish and poultry. Beans, nuts, fruit and vegetables should also be incorporated. Whole foods and raw foods are the best.
 Serrapeptase is thought to work in three ways:
  1. It may reduce inflammation by thinning the fluids formed from injury, and facilitating the fluid’s drainage. This in turn, also speeds tissue repair.
  2. It may help alleviate pain by inhibiting the release of pain-inducing amines called bradykinin.
  3. It may enhance cardiovascular health by breaking down the protein by-products of blood coagulation called fibrin. Conveniently, Serrapeptase is able to dissolve the fibrin and other dead or damaged tissue without harming living tissue. This could enable the dissolution of atherosclerotic plaques without causing any harm to the inside of the arteries. 

Serrapeptase has been used in Europe and Asia for over 25 years. Because the enzyme digests or dissolves all nonliving tissue, including blood clots, cysts and arterial plaque, it is used to treat a variety of conditions, including sprains and torn ligaments, postoperative swelling, venous thrombosis (clots in the legs), ear, nose and throat infections and atherosclerosis.

Abroad, Serrapeptase is marketed under a variety of names including, DanzenTM, AniflazymTM, and SerraZymeTM. In the United States, it has been used and marketed as Serrapeptase since 1997. A pain-reliever and anti-inflammatory supplement that has anti-clotting activities without the risk of stomach bleeding? Sounds too good to be true? Let’s look at the research.
 

No comments:

Post a Comment